ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Samuel Broder Plans To Leave Celera.

September 10, 2010

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In

August 15, 1980

Tri-Institutional Stem Cell Initiative Funds Grants.

August 4, 2006

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996